Georgia Chenevix-Trench

Last updated

Georgia Chenevix-Trench FAA , FAHMS (born 8 February 1959) is an Australian cancer researcher who investigates genetic predispositions to cancer.

Chenevix-Trench was born in Nairobi, Kenya. [1] She received her undergraduate degree (BSc(Hons)) in 1980 from the department of genetics at Trinity College in Ireland and was subsequently awarded her PhD in 1985 from the department of human genetics at the Medical College of Virginia, USA. [2] [3] and in 1986 she commenced her post-doctoral work there. In 1989 she moved to Australia where she started working as a research officer at the Queensland Institute of Medical Research (QIMR). She currently works at the QIMR Berghofer Medical Research Institute, where she heads a cancer genetics research lab. [4]

Chenevix-Trench has published over 400 papers in peer reviewed journals and has been actively involved in science education and communication. [2]

She was elected to the Australian Academy of Science in 2014, for her work on the genetics of breast, ovarian and other cancers, including showing that mutations in the ATM gene confer moderate risks for breast cancer. [5] In 2015 she was elected Fellow of the Australian Academy of Health and Medical Sciences. [6] She was awarded the Suzanne Cory Medal and Lecture by the Australian Academy of Science in 2022. [7]

Related Research Articles

Jerry McKee Adams, FAA, FRS, FAHMS, FRSV is an Australian-American molecular biologist whose research into the genetics of haemopoietic differentiation and malignancy, led him and his wife, Professor Suzanne Cory, to be the first two scientists to pioneer gene cloning techniques in Australia, and to successfully clone mammalian genes.

The QIMR Berghofer Medical Research Institute is an Australian medical research institute located in Herston, Brisbane, in the state of Queensland. QIMR was established in 1945 by the Government of Queensland through the enactment of the Queensland Institute of Medical Research Act 1945 (Qld). Previously known as the Queensland Institute of Medical Research (QIMR), the original purpose of the institute was to further the study of tropical diseases in North Queensland. The current director is Professor Fabienne Mackay. The institute is a registered charity. In 2021, the institute was named as one of the Queensland Greats by the Queensland Government.

Michael F. Good was the Director of the Queensland Institute of Medical Research, from 2000 to 2010. He was Chair of the National Health and Medical Research Council.

<span class="mw-page-title-main">Mary-Claire King</span> American geneticist

Mary-Claire King is an American geneticist. She was the first to show that breast cancer can be inherited due to mutations in the gene she called BRCA1. She studies human genetics and is particularly interested in genetic heterogeneity and complex traits. She studies the interaction of genetics and environmental influences and their effects on human conditions such as breast and ovarian cancer, inherited deafness, schizophrenia, HIV, systemic lupus erythematosus and rheumatoid arthritis. She has been the American Cancer Society Professor of the Department of Genome Sciences and of Medical Genetics in the Department of Medicine at the University of Washington since 1995.

Suzanne Cory is an Australian molecular biologist. She has worked on the genetics of the immune system and cancer and has lobbied her country to invest in science. She is married to fellow scientist Jerry Adams, also a WEHI scientist, whom she met while studying for her PhD at the University of Cambridge, England.

Nicholas Gordon Martin is an Australian behavior geneticist who has published over 1300 peer-reviewed articles on topics including the heritability of religion and intelligence and medical disorders such as endometriosis. Martin is among the most cited medical scientists in the Southern Hemisphere, with a number of citation classics including "Genes, culture and personality: An empirical approach" that he co-authored with Lindon Eaves and Hans Eysenck, "Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus" (Nature, and "Genetic and environmental contributions to alcohol dependence risk in a national twin sample".

<span class="mw-page-title-main">Olufunmilayo Olopade</span> Nigerian physician

Olufunmilayo I. Olopade born in the year 1957, is a Nigerian hematology oncologist, Associate Dean for Global Health and Walter L. Palmer, Distinguished Service Professor in Medicine and Human Genetics at the University of Chicago. She also serves as director of the University of Chicago Hospital's Cancer Risk Clinic.

Kum Kum Khanna is an Indian professor at the QIMR Berghofer Medical Research Institute, also known as Queensland Institute of Medical Research who has published many peer reviewed articles in reputable journals such as in Nature Genetics, Cancer Cell, Nature, Oncogene, and many others. Her most cited article has received 1568 citations since its publication in 2001. she has made seminal discoveries in identifying single-stranded DNA binding proteins, hSSB1 and hSSB2 involved in DNA repair; a novel protein, designated as Cep55, involved in regulation of final stage of cell cycle and have functionally characterized BRCA2 interacting protein, Centrobin.

Judith Ann Clements is an Australian academic and educator, specializing in Kallikrein proteases in prostate and ovarian cancers. Clements is the scientific director at the Australian Prostate Cancer Research Centre – Queensland and was head of the Cancer Research Program at the Institute of Health and Biomedical Innovation (IHBI) of Queensland University of Technology at the Translational Research Institute (Australia) from 1997–2014.

Health Translation Queensland (formerly Brisbane Diamantina Health Partners is the first Advanced Health Research Translation Centre in Queensland, Australia.

Melanie Bahlo is an Australian statistical geneticist and bioinformatician.

<span class="mw-page-title-main">Frank Gannon</span> Irish molecular biologist

Frank Gannon was the seventh Director of QIMR Berghofer Medical Research Institute in Brisbane, Australia. He is a molecular biologist and has held high-profile appointments in scientific management and research in Ireland, England, the United States, France, Germany and Australia.

Sarah-Jane Dawson is an Australian clinician-scientist. She is a consultant medical oncologist and head of the Molecular Biomarkers and Translational Genomics Laboratory at the Peter MacCallum Cancer Centre in Melbourne. Her current research interests are focused on the development of noninvasive blood-based biomarkers for clinical application, including early detection, risk stratification and disease monitoring in cancer management.

Adele Chandler Green is an Australian epidemiological senior scientist at the QIMR Berghofer Medical Research Institute in Brisbane and is the institute's Head of Cancer and Population Studies Group.

Alan Frederick Cowman AC, FRS, FAA, CorrFRSE, FAAHMS, FASP, FASM is an internationally acclaimed malaria researcher whose work specialises in researching the malaria-causing parasite, Plasmodium falciparum, and the molecular mechanisms it uses to evade host responses and antimalarial drugs. He is currently deputy directory of the Walter and Eliza Hall Institute of Medical Research (WEHI) in Melbourne, and his laboratory continues to work on understanding how Plasmodium falciparum, infects humans and causes disease. He was elected as a fellow of the Royal Society in 2011 and awarded the Companion of the Order of Australia in 2019 for his "eminent service to the biological sciences, notably to molecular parasitology, to medical research and scientific education, and as a mentor."

Professor Anne Kelso is an Australian biomedical researcher specialising in immunology and influenza. She is the Chief Executive Officer of the Australian Government's National Health and Medical Research Council (NHMRC).

Professor Susan J. Clark is an Australian biomedical researcher in epigenetics of development and cancer. She was elected a Fellow of the Australian Academy of Science in 2015, and is a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellow and Research Director and Head of Genomics and Epigenetics Division at the Garvan Institute of Medical Research. Clark developed the first method for bisulphite sequencing for DNA methylation analysis and used it to establish that the methylation machinery of mammalian cells is capable of both maintenance and de novo methylation at CpNpG sites and showed is inheritable. Clark's research has advanced understanding of the role of DNA methylation, non-coding RNA and microRNA in embryogenesis, reprogramming, stem cell development and cancer and has led to the identification of epigenomic biomarkers in cancer. Clark is a founding member of the International Human Epigenome Consortium (IHEC) and President of the Australian Epigenetics Alliance (AEpiA).

Sarah Elizabeth Medland is Professor and Psychiatric Genetics Group Leader at the QIMR Berghofer Medical Research Institute in Herston, Brisbane, Australia. She played a major role in the development of the ENIGMA brain imaging consortium.

Fabienne Mackay is a French Australian research immunologist and institutional leader within the Australian medical research, education and innovation sectors. She is the Director and CEO of the QIMR Berghofer Medical Research Institute since 2020, after being the inaugural Head of the School of Biomedical Sciences at the University of Melbourne during the preceding five years. She is also an Honorary Professor at the Faculties of Medicine of the University of Queensland and the University of Melbourne. Her work has attracted public attention for its contribution to the pathophysiological understanding and treatment of lupus and other autoimmune diseases. Mackay has been notably awarded, achieving international reputation for her widely cited research describing B-cell activating factor (BAFF) and other cytokines of the TNF receptor superfamily, and their roles in B cell physiology, autoimmunity and cancer. She is an elected Fellow of the Australian Academy of Health and Medical Sciences.

Lyn Robyn Griffiths is an Australian academic who serves as Distinguished Professor of molecular genetics at Queensland University of Technology, where she is director of the Centre for Genomics and Personalised Health, the Genomics Research Centre and the BridgeTech Programs. Griffiths is internationally renowned for her work in the discovery of the genetics of migraine headaches.

References

  1. ↑ Who's Who Australian Women (2017), ConnectWeb.
  2. 1 2 "Participant 3 - The Queensland Institute of Medical Research (QIMR)". COGS - Collaborative Oncological Gene-environment Study. Retrieved 21 April 2015.
  3. ↑ "Professor Georgia Chenevix-Trench". ACRF Advisory Committee. Retrieved 21 April 2015.
  4. ↑ "Cancer Genetics - Senior Scientist Professor Georgia Chenevix-Trench". QIMR Berghofer Medical Research Institute. Archived from the original on 14 April 2015. Retrieved 21 April 2015.
  5. ↑ "Professor Georgia Chenevix-Trench | Australian Academy of Science". www.science.org.au. Retrieved 25 June 2018.
  6. ↑ "Fellowship | AAHMS – Australian Academy of Health and Medical Sciences". www.aahms.org. Retrieved 25 June 2018.
  7. ↑ "2022 awardees". Australian Academy of Science. Retrieved 31 March 2022.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.